Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Phibro Anl Htlh A (PAHC)

Phibro Anl Htlh A (PAHC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,637,979
  • Shares Outstanding, K 40,534
  • Annual Sales, $ 1,296 M
  • Annual Income, $ 48,260 K
  • EBIT $ 144 M
  • EBITDA $ 192 M
  • 60-Month Beta 0.77
  • Price/Sales 1.27
  • Price/Cash Flow 12.42
  • Price/Book 5.28

Options Overview Details

View History
  • Implied Volatility 70.87% (+20.71%)
  • Historical Volatility 45.59%
  • IV Percentile 85%
  • IV Rank 50.81%
  • IV High 107.65% on 01/13/25
  • IV Low 32.88% on 07/08/25
  • Expected Move (DTE 28) 2.81 (7.53%)
  • Put/Call Vol Ratio 1.18
  • Today's Volume 24
  • Volume Avg (30-Day) 33
  • Put/Call OI Ratio 0.33
  • Today's Open Interest 901
  • Open Int (30-Day) 847
  • Expected Range 34.45 to 40.06

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 0.69
  • Number of Estimates 4
  • High Estimate 0.72
  • Low Estimate 0.64
  • Prior Year 0.54
  • Growth Rate Est. (year over year) +27.78%

Price Performance

See More
Period Period Low Period High Performance
1-Month
36.14 +3.07%
on 12/19/25
44.72 -16.71%
on 11/25/25
-4.13 (-9.98%)
since 11/19/25
3-Month
35.81 +4.02%
on 10/10/25
46.42 -19.75%
on 11/11/25
-2.61 (-6.55%)
since 09/19/25
52-Week
16.16 +130.51%
on 04/21/25
46.42 -19.75%
on 11/11/25
+15.44 (+70.79%)
since 12/19/24

Most Recent Stories

More News
Phibro Animal Health Corporation Announces Leadership Transition

Jack Bendheim to Assume the Role of Executive Chairman; Daniel Bendheim Named Chief Executive Officer and President

PAHC : 37.25 (-7.82%)
Phibro: Fiscal Q1 Earnings Snapshot

Phibro: Fiscal Q1 Earnings Snapshot

PAHC : 37.25 (-7.82%)
Phibro Animal Health Corporation Reports First Quarter Results, Updates Financial Guidance

Phibro Animal Health Corporation (Nasdaq: PAHC) (“Phibro” or the “Company”) today announced financial results for its first quarter ended September 30, 2025 and its updated financial guidance for...

PAHC : 37.25 (-7.82%)
Phibro Animal Health Corporation Declares Quarterly Dividend

The Board of Directors of Phibro Animal Health Corporation (Nasdaq: PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on December...

PAHC : 37.25 (-7.82%)
Phibro Animal Health Corporation Announces National Launch of Restoris™ Piezoelectric Dental Gel for Dogs

Phibro Animal Health Corporation is proud to announce the national launch of Restoris™ piezoelectric dental gel, a revolutionary dental gel designed to treat and support long-term oral health in dogs...

PAHC : 37.25 (-7.82%)
Phibro Animal Health Corporation to Host Webcast and Conference Call on First Quarter Results

Phibro Animal Health Corporation (Nasdaq: PAHC) expects to announce its first quarter financial results on Wednesday, November 5, 2025, after the market closes. Phibro management will host a conference...

PAHC : 37.25 (-7.82%)
Phibro Animal Health Corporation to Host Webcast and Conference Call on First Quarter Results

Phibro Animal Health Corporation (Nasdaq: PAHC) expects to announce its first quarter financial results on Wednesday, November 5, 2025, after the market closes. Phibro management will host a conference...

PAHC : 37.25 (-7.82%)
Phibro Animal Health Corporation Announces Licensing Agreement with Lighthouse Pharmaceuticals, Inc. for Innovative Periodontal Health Asset for Dogs

Phibro Animal Health Corporation (Nasdaq: PAHC), a global leader in animal health and nutrition, today announced it has entered into a licensing agreement with Lighthouse Pharmaceuticals, Inc. for a novel...

PAHC : 37.25 (-7.82%)
Phibro Animal Health Corporation to Participate at Morgan Stanley Annual Global Healthcare Conference

Phibro Animal Health Corporation (Nasdaq: PAHC) announced today it will participate in the Morgan Stanley Annual Global Healthcare Conference. Chief Financial Officer, Glenn David will address...

PAHC : 37.25 (-7.82%)
Is it Apt to Hold Bio-Rad Stock in Your Portfolio Now?

Bio-Rad Laboratories, Inc. BIO is well-poised to grow in the upcoming quarters, courtesy of its strong traction in the QX600 Droplet Digital PCR (ddPCR) platform. Demand for its quality control and immunology...

MASI : 134.04 (-1.92%)
BIO : 301.53 (+0.56%)
PAHC : 37.25 (-7.82%)
NVST : 22.28 (+0.13%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Phibro Animal Health Corporation is a leading global diversified animal health and mineral nutrition company. The company provides a broad range of products for food animals including poultry, swine, beef and dairy cattle and aquaculture. In addition to animal health and mineral nutrition products, Phibro...

See More

Key Turning Points

3rd Resistance Point 43.09
2nd Resistance Point 41.48
1st Resistance Point 39.36
Last Price 37.25
1st Support Level 35.64
2nd Support Level 34.03
3rd Support Level 31.91

See More

52-Week High 46.42
Last Price 37.25
Fibonacci 61.8% 34.86
Fibonacci 50% 31.29
Fibonacci 38.2% 27.72
52-Week Low 16.16

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar